AbbVie Inc. (NYSE: ABBV ) is one of the best undervalued stocks to invest in right now.

The OriGAMI-4 trial reveals subcutaneous Rybrevant's 45% response rate in metastatic head and neck cancer patients after ...

Please provide your email address to receive an email when new articles are posted on . Subcutaneous implantable cardioverter defibrillators can prevent arrhythmic death for people with congenital ...

Please provide your email address to receive an email when new articles are posted on . Rates of skin and subcutaneous diseases varied greatly across U.S. regions and states, according to findings ...

A subcutaneous formulation of anifrolumab would allow patients the ability to self-administer the medication outside of a hospital or clinic setting. Full results were announced from a phase 3 trial ...

− If approved, the additional treatment modality will provide more options for how patients in Europe receive the gut-selective biologic vedolizumab − Recommendation brings vedolizumab one step closer ...

Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological ...

What is the difference between visceral and subcutaneous fat Read ahead to know as an expert explains which type of belly fat ...

Clinician and patient responses for cutaneous cGVHD were associated with higher nonrelapse mortality when comparing worsening vs improved disease.

AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3, randomized, placebo-controlled, double-blind AFFIRM study evaluating the efficacy and safety of risankizumab (SKYRIZI®) ...